0
0
HYDERABAD — Researchers at the Indian Council of Medical Research–National Institute of Nutrition (ICMR-NIN) have announced the development of a standardised poly-herbal extract (PHE) designed to combat the growing dual crises of diabetes and obesity. Unlike traditional treatments that focus primarily on lowering blood sugar, this new formulation targets the biological “roots” of organ damage—including kidney disease, vision loss, and nerve disorders. Composed of five common culinary and medicinal plants—ginger, cinnamon, black pepper, amla, and turmeric—the extract is now transitioning from successful laboratory trials into clinical evaluation to determine its efficacy and safety for human use.
A Pathway-Centric Approach to Metabolic Health
For decades, the standard of care for Type 2 diabetes has centered on a single metric: the HbA1c, or average blood glucose level. While maintaining stable glucose is vital, many patients continue to suffer from debilitating complications like chronic kidney disease (nephropathy) and retinal damage (retinopathy) even when their “numbers” appear controlled.
The ICMR-NIN team, led by Dr. Bhanuprakash Reddy, Scientist G, is shifting the focus toward the underlying mechanisms of tissue damage. The newly developed Poly-Herbal Extract (PHE) specifically targets:
-
Chronic Inflammation: The persistent, low-grade immune response that fuels insulin resistance.
-
Oxidative Stress: The imbalance of free radicals that damages cellular structures.
-
Advanced Glycation End-products (AGEs): Harmful compounds that form when protein or fat combine with sugar in the bloodstream, leading to “stiffening” of blood vessels and nerves.
-
The Aldose Reductase Pathway: A biochemical route that, when overactive due to high sugar, is directly linked to the development of cataracts and diabetic neuropathy.
“Management of diabetes and obesity must evolve beyond simple glucose monitoring,” Dr. Reddy stated during the announcement. He emphasized that by acting through multiple biological pathways, this formulation seeks to “arrest the progression of long-term complications” rather than just managing symptoms.
From the Kitchen to the Lab: The Science of the Five Plants
The formulation leverages the synergistic effects of bioactive compounds found in everyday Indian staples. While these ingredients have been used in traditional medicine for centuries, the ICMR-NIN’s breakthrough lies in standardisation.
In preclinical studies, this refined mixture showed significantly enhanced activity compared to previous, unrefined herbal blends. The specific synergy of curcumin (turmeric), piperine (black pepper), gingerols (ginger), and the high antioxidant content of amla and cinnamon appears to create a potent defense against metabolic damage.
In animal models, the extract demonstrated protective effects against:
-
Nephropathy: Reducing markers of kidney strain.
-
Retinopathy and Cataracts: Protecting the delicate tissues of the eye from glucose-induced degradation.
-
Neuronal Injury: Shielding the peripheral nerves that, when damaged, lead to diabetic foot ulcers.
Statistical Context: The Rising Burden
The timing of this development is critical. According to recent health data, India is home to over 70 million people living with diabetes, with millions more classified as pre-diabetic or obese. The economic and social cost of managing end-stage complications, such as dialysis for kidney failure or surgery for vision loss, threatens to overwhelm the public health infrastructure.
Expert Perspectives and Clinical Caution
While the research is promising, the medical community maintains a stance of “cautious optimism.” Outside experts stress that laboratory success in rodents does not always translate to human biology.
Dr. Anoop Misra, a renowned endocrinologist and former head of the Fortis-C-DOC Centre of Excellence in Diabetes, who was not involved in the study, highlights the necessity of the upcoming trials. “Any intervention that claims to affect glucose, weight, or kidney or eye outcomes in diabetes must be tested in randomised, controlled trials with clear endpoints before being recommended,” Dr. Misra noted.
He further cautioned that while plant-based extracts can be helpful adjuncts, they “should neither replace proven therapies nor be used without medical supervision in people on insulin or multiple drugs.”
Dr. Bharati Kulkarni, Director of ICMR-NIN, echoed the need for rigorous testing, noting that the formulation is currently being evaluated in human clinical trials to establish definitive safety profiles and dosages.
Practical Implications: What This Means for You
For the health-conscious consumer, this news highlights a growing shift toward integrative medicine—the combination of standard pharmacological treatments with science-backed nutraceuticals. However, it is important to distinguish between “culinary use” and “therapeutic use.”
-
Continue Standard Care: Patients should not stop taking prescribed medications like metformin or insulin in favor of herbal supplements.
-
Dietary Integration: Incorporating ginger, turmeric, amla, and cinnamon into your daily meals is generally safe and provides nutritional benefits, but these should be viewed as part of a healthy lifestyle, not a “cure.”
-
Watch for Interactions: High doses of herbal extracts can interact with blood thinners or glucose-lowering drugs. Always inform your doctor about any supplements you are taking.
Looking Ahead: A Potential Public Health Milestone
If clinical trials prove successful, the ICMR-NIN poly-herbal extract could become an affordable, accessible tool in the global fight against non-communicable diseases. By shifting the focus from the glucometer to the organs themselves, researchers hope to improve the quality of life for millions, ensuring that a diagnosis of diabetes does not inevitably lead to a loss of mobility or sight.
References
-
NDTV Health (2026): “ICMR-NIN develops poly-herbal extract to tackle diabetes and obesity complications.” Published March 24, 2026.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
